{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:38:52Z","timestamp":1793385532779,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100019535","name":"Texas Tech University Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3\/UH3 DA048353 01"],"award-info":[{"award-number":["UG3\/UH3 DA048353 01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpet.2025.103720","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:50:31Z","timestamp":1758567031000},"page":"103720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mitragynine and 7-hydroxymitragynine: Bidirectional effects on breathing in rats"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7543-6892","authenticated-orcid":false,"given":"Julio D.","family":"Zuarth Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1213-4789","authenticated-orcid":false,"given":"Alexandria K.","family":"Ragsdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8947-0783","authenticated-orcid":false,"given":"Sushobhan","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0360-6318","authenticated-orcid":false,"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9644-0750","authenticated-orcid":false,"given":"Samuel","family":"Obeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Wilkerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.jpet.2025.103720_bib1","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.2174\/138161212803582469","article-title":"Non-analgesic effects of opioids: opioid-induced respiratory depression","volume":"18","author":"Boom","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.jpet.2025.103720_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib4","first-page":"24","article-title":"Kratom (mitragynine) ingestion requiring naloxone reversal","volume":"3","author":"Overbeek","year":"2019","journal-title":"Clin Pract Cases Emerg Med"},{"issue":"13","key":"10.1016\/j.jpet.2025.103720_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain\u2014misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jpet.2025.103720_bib6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chest.2019.05.015","article-title":"Solving the opioid crisis: respiratory depression by opioids as critical end point","volume":"156","author":"Montandon","year":"2019","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1113\/JP278612","article-title":"Differential impact of two critical respiratory centres in opioid-induced respiratory depression in awake mice","volume":"598","author":"Varga","year":"2020","journal-title":"J Physiol"},{"issue":"12","key":"10.1016\/j.jpet.2025.103720_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024086","article-title":"Risk factors for opioid-induced respiratory depression in surgical patients: a systematic review and meta-analyses","volume":"8","author":"Gupta","year":"2018","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.jpet.2025.103720_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1750-2659.2011.00198.x","article-title":"A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers","volume":"5","author":"MacIntyre","year":"2011","journal-title":"Influ Other Respir Viruses"},{"key":"10.1016\/j.jpet.2025.103720_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2019.05.005","article-title":"Kratom as a substitute for opioids: results from an online survey","volume":"202","author":"Coe","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103720_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1411964","article-title":"Commentary: presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report","volume":"15","author":"Grundmann","year":"2024","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jpet.2025.103720_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugalcdep.2017.10.012","article-title":"Kratom use and mental health: a systematic review","volume":"183","author":"Swogger","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"21","key":"10.1016\/j.jpet.2025.103720_bib13","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1021\/jacs.6b00360","article-title":"Synthetic and receptor signaling explorations of the mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators","volume":"138","author":"Kruegel","year":"2016","journal-title":"J Am Chem Soc"},{"issue":"18","key":"10.1016\/j.jpet.2025.103720_bib14","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit beta-arrestin-2","volume":"59","author":"Varadi","year":"2016","journal-title":"J Med Chem"},{"issue":"18","key":"10.1016\/j.jpet.2025.103720_bib15","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.3390\/molecules25184257","article-title":"Biased opioid ligands","volume":"25","author":"Faouzi","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.jpet.2025.103720_bib16","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/bph.14913","article-title":"G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder","volume":"177","author":"Gutridge","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"13","key":"10.1016\/j.jpet.2025.103720_bib17","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/bph.14224","article-title":"The novel mu-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception","volume":"175","author":"Hill","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.jpet.2025.103720_bib18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.tips.2018.08.007","article-title":"Abuse potential of biased mu opioid receptor agonists","volume":"39","author":"Negus","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41467-018-08162-1","article-title":"Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects","volume":"10","author":"Kliewer","year":"2019","journal-title":"Nat Commun"},{"issue":"13","key":"10.1016\/j.jpet.2025.103720_bib20","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/bph.15004","article-title":"Morphine-induced respiratory depression is independent of beta-arrestin2 signalling","volume":"177","author":"Kliewer","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"13","key":"10.1016\/j.jpet.2025.103720_bib21","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00213-015-3866-5","article-title":"Discriminative stimulus properties of mitragynine (kratom) in rats","volume":"232","author":"Harun","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"issue":"10","key":"10.1016\/j.jpet.2025.103720_bib22","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00213-018-4974-9","article-title":"Abuse liability of mitragynine assessed with a self-administration procedure in rats","volume":"235","author":"Yue","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.jpet.2025.103720_bib23","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/adb.12639","article-title":"Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine","volume":"24","author":"Hemby","year":"2019","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103720_bib24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.120.000189","article-title":"Pharmacological comparison of mitragynine and 7-hydroxymitragynine: in vitro affinity and efficacy for mu-opioid receptor and opioid-like behavioral effects in rats","volume":"376","author":"Obeng","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"issue":"17","key":"10.1016\/j.jpet.2025.103720_bib25","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.lfs.2003.09.054","article-title":"Antinociceptive effect of 7-hydroxymitragynine in mice: discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa","volume":"74","author":"Matsumoto","year":"2004","journal-title":"Life Sci"},{"issue":"1\u20133","key":"10.1016\/j.jpet.2025.103720_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2006.08.013","article-title":"Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa","volume":"549","author":"Matsumoto","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103720_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13181-016-0588-y","article-title":"Suspected adulteration of commercial kratom products with 7-hydroxymitragynine","volume":"12","author":"Lydecker","year":"2016","journal-title":"J Med Toxicol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103720_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/add.16728","article-title":"The rise of novel, semi-synthetic 7-hydroxymitragnine products","volume":"120","author":"Smith","year":"2025","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jpet.2025.103720_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11419-009-0070-5","article-title":"Simultaneous analysis of mitragynine, 7-hydroxymitragynine, and other alkaloids in the psychotropic plant \u201ckratom\u201d (Mitragyna speciosa) by LC-ESI-MS","volume":"27","author":"Kikura-Hanajiri","year":"2009","journal-title":"Forensic Toxicol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76119-w","article-title":"Chemical composition and biological effects of kratom (Mitragyna speciosa): in vitro studies with implications for efficacy and drug interactions","volume":"10","author":"Todd","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jpet.2025.103720_bib31","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/acs.jnatprod.0c01055","article-title":"Exploring the chemistry of alkaloids from Malaysian Mitragyna speciosa (kratom) and the role of oxindoles on human opioid receptors","volume":"84","author":"Chear","year":"2021","journal-title":"J Nat Prod"},{"issue":"12","key":"10.1016\/j.jpet.2025.103720_bib32","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1007\/s00213-022-06244-z","article-title":"Respiratory effects of oral mitragynine and oxycodone in a rodent model","volume":"239","author":"Henningfield","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"14","key":"10.1016\/j.jpet.2025.103720_bib33","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1111\/bph.15832","article-title":"The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine","volume":"179","author":"Hill","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2025.103720_bib34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/biom13060935","article-title":"Hyperactivity in mice induced by opioid agonists with partial intrinsic efficacy and biased agonism administered alone and in combination with morphine","volume":"13","author":"Acevedo-Canabal","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpet.2025.103720_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuropharm.2019.03.023","article-title":"Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances","volume":"151","author":"Varshneya","year":"2019","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.jpet.2025.103720_bib36","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00213-011-2432-z","article-title":"Morphine-induced motor stimulation, motor incoordination, and hypothermia in adolescent and adult mice","volume":"219","author":"Koek","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2025.103720_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(94)90342-5","article-title":"The role of dopamine D1-receptors in morphine-induced hyperlocomotion in mice","volume":"169","author":"Funada","year":"1994","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.jpet.2025.103720_bib38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0022-3565(25)28807-3","article-title":"Effects of narcotic analgesics upon the locomotor activity and brain catecholamine content of the mouse","volume":"176","author":"Rethy","year":"1971","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103720_bib39","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"issue":"6","key":"10.1016\/j.jpet.2025.103720_bib40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1055\/s-2006-959578","article-title":"A new indole alkaloid, 7 \u03b1-hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand","volume":"60","author":"Ponglux","year":"1994","journal-title":"Planta Med"},{"issue":"4","key":"10.1016\/j.jpet.2025.103720_bib41","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1152\/japplphysiol.00080.2002","article-title":"A reevaluation of the validity of unrestrained plethysmography in mice","volume":"93","author":"Lundblad","year":"2002","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1542\/peds.16.1.81","article-title":"A barometric method for measuring ventilation in newborn infants","volume":"16","author":"Drorbaugh","year":"1955","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.jpet.2025.103720_bib43","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1301552","article-title":"Cannabinoid CB1 receptor antagonists attenuate cocaine\u2019s rewarding effects: experiments with self-administration and brain-stimulation reward in rats","volume":"33","author":"Xi","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.jpet.2025.103720_bib44","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/npp.2014.3","article-title":"Long-term reduction of cocaine self-administration in rats treated with adenoviral vector-delivered cocaine hydrolase: evidence for enzymatic activity","volume":"39","author":"Zlebnik","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103720_bib45","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1152\/jappl.2000.89.3.908","article-title":"Comparative respiratory system mechanics in rodents","volume":"89","author":"Gomes","year":"2000","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jpet.2025.103720_bib46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1152\/jappl.1964.19.2.360","article-title":"Ventilation standards for small mammals","volume":"19","author":"Kleinman","year":"1964","journal-title":"J Appl Physiol"},{"issue":"2P2","key":"10.1016\/j.jpet.2025.103720_bib47","first-page":"S77","article-title":"Comparative mammalian respiratory mechanics","volume":"128","author":"Leith","year":"1983","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"10.1016\/j.jpet.2025.103720_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12576-015-0408-1","article-title":"Plethysmography measurements of respiratory function in conscious unrestrained mice","volume":"66","author":"Quindry","year":"2016","journal-title":"J Physiol Sci"},{"issue":"3","key":"10.1016\/j.jpet.2025.103720_bib49","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(25)31491-6","article-title":"Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment","volume":"207","author":"McGilliard","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2025.103720_bib50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1213\/00000539-197352030-00033","article-title":"Naloxone for antagonism of morphine-induced respiratory depression","volume":"52","author":"Longnecker","year":"1973","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2044.1980.tb03714.x","article-title":"Antagonists of morphine-induced respiratory depression: a study in postoperative patients","volume":"35","author":"Gairola","year":"1980","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib52","doi-asserted-by":"crossref","first-page":"L97","DOI":"10.1152\/ajplung.00045.2025","article-title":"Reversal of morphine-induced respiratory depression with the \u03bc1-opioid receptor antagonist naloxonazine engenders excitation and instability of breathing","volume":"329","author":"Getsy","year":"2025","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103720_bib53","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.toxlet.2014.12.007","article-title":"Reversal of opioid overdose syndrome in morphine-dependent rats using buprenorphine","volume":"232","author":"Zamani","year":"2015","journal-title":"Toxicol Lett"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0304-3959(95)00088-7","article-title":"Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers","volume":"64","author":"Borgbjerg","year":"1996","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jpet.2025.103720_bib55","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF00403646","article-title":"Adrenergic and serotonergic mechanisms in morphine-induced respiratory depression","volume":"24","author":"Fl\u00f3rez","year":"1972","journal-title":"Psychopharmacologia"},{"issue":"2","key":"10.1016\/j.jpet.2025.103720_bib56","first-page":"145","article-title":"Respiratory depression following morphine and morphine-6-glucuronide in normal subjects","volume":"40","author":"Thompson","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpet.2025.103720_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108310","article-title":"Lyophilized kratom tea as a therapeutic option for opioid dependence","volume":"216","author":"Wilson","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.jpet.2025.103720_bib58","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jat\/bkz108","article-title":"CYP450-mediated metabolism of mitragynine and investigation of metabolites in human urine","volume":"44","author":"Basiliere","year":"2020","journal-title":"J Anal Toxicol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103720_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.122.001525","article-title":"Pharmacokinetic and pharmacodynamic consequences of cytochrome P450 3A inhibition on mitragynine metabolism in rats","volume":"385","author":"Kamble","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.jpet.2025.103720_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/0974-8490.118806","article-title":"Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities","volume":"5","author":"Hanapi","year":"2013","journal-title":"Pharmacognosy Res"},{"key":"10.1016\/j.jpet.2025.103720_bib61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.toxlet.2019.11.005","article-title":"Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids","volume":"319","author":"Kamble","year":"2020","journal-title":"Toxicol Lett"},{"issue":"2","key":"10.1016\/j.jpet.2025.103720_bib62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/dmd.121.000640","article-title":"The lack of contribution of 7-hydroxymitragynine to the antinociceptive effects of mitragynine in mice: a pharmacokinetic and pharmacodynamic study","volume":"50","author":"Berthold","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib63","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acs.jmedchem.9b01465","article-title":"Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based kratom alkaloids","volume":"63","author":"Obeng","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2025.103720_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176863","article-title":"The Mitragyna speciosa (kratom) alkaloid mitragynine: analysis of adrenergic \u03b12 receptor activity in vitro and in vivo","volume":"980","author":"Obeng","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103720_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth Prog"},{"issue":"11","key":"10.1016\/j.jpet.2025.103720_bib66","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/clc.4960131104","article-title":"Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism","volume":"13","author":"Nash","year":"1990","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jpet.2025.103720_bib67","series-title":"Kratom and Other Mitragynines: the Chemistry and Pharmacology of Opioids From a Non-opium Source","author":"Raffa","year":"2014"},{"issue":"11","key":"10.1016\/j.jpet.2025.103720_bib68","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/00498254.2018.1552819","article-title":"Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom)","volume":"49","author":"Kamble","year":"2019","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/j.jpet.2025.103720_bib69","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acscentsci.9b00141","article-title":"7-hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects","volume":"5","author":"Kruegel","year":"2019","journal-title":"ACS Cent Sci"},{"issue":"3","key":"10.1016\/j.jpet.2025.103720_bib70","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1021\/acsptsci.3c00335","article-title":"Effects of itraconazole on pharmacokinetics of mitragynine and 7-hydroxymitragynine in healthy volunteers","volume":"7","author":"Mongar","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"7_Suppl_1","key":"10.1016\/j.jpet.2025.103720_bib71","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1212\/WNL.0000000000210320","article-title":"Kratom-induced seizures: an emerging public health crisis","volume":"104","author":"Fletcher","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.jpet.2025.103720_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112701","article-title":"De facto opioids: characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing","volume":"272","author":"Hill","year":"2025","journal-title":"Drug Alcohol Depend"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652540233X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652540233X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:18:03Z","timestamp":1764058683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652540233X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S002235652540233X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103720","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitragynine and 7-hydroxymitragynine: Bidirectional effects on breathing in rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103720"}}